Intrinsiqs

Is Faeth Therapeutics, Inc. overvalued?

Faeth Therapeutics, Inc. (FTH) — key valuation metrics and fundamentals.

No verdict
Price
$28.00
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$721.8M
Dividend yield
0.0%
Return on equity
-192.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares FTH's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.